News
-
-
-
PRESS RELEASE
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Bausch Health's additional ACG presentation to focus on Xifaxan impact on OHE rehospitalizations and Plenvu bowel preparation efficacy at ACG 2024. Posters to share findings on treatments -
-
-
-
-
-
PRESS RELEASE
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Bausch Health Companies Inc. and Salix Pharmaceuticals release Liver Health Trends Report highlighting need for improved chronic liver disease care, education, and management -